An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

Elizabeth S. Waxman, RN, MSN, NP-C, AOCN®
The University of Texas MD Anderson Cancer Center

Posted: 11/21/2017
Expires: 11/21/2018
Estimated time to complete: 1 hour

Instructions for Earning CE credit

This activity has expired, credit is no longer available.

rowCount++; var rowCount = 0; rowCount++;

Quick Tips

How do you identify and manage adverse events?
How do you interpret a patient’s therapeutic response to treatment?
What are the genetic variants in NSCLC, and how are they used to select treatment?
What is the current thinking on diagnosis and treatment of patients with squamous cell NSCLC?
What are the mechanisms of action of targeted treatments and immunotherapies?
Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.